Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide

for the RESUME trialists

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
JournalLeukemia
DOIs
Publication statusAccepted/In press - 1 Jan 2020

Cite this